Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Clinical trial NCT03061955 · COMPLETED

Trial details

NCT number: NCT03061955
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Study type: OBSERVATIONAL

Influenza Virus Vaccine Adverse Reaction (Disorder)Influenza Malignancy

Start date: 2016-10-01
Primary completion: 2017-03-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.